|
WWP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.72029999999657E-05 |
| Normal-vs-Stage3 |
7.78309972027103E-10 |
| Normal-vs-Stage4 |
7.963500E-03 |
| Stage1-vs-Stage2 |
2.096200E-01 |
| Stage1-vs-Stage3 |
4.738600E-01 |
| Stage1-vs-Stage4 |
4.647200E-01 |
| Stage2-vs-Stage3 |
5.355400E-01 |
| Stage2-vs-Stage4 |
8.767200E-01 |
| Stage3-vs-Stage4 |
7.791400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.13600281695881E-11 |
| Normal-vs-Asian |
7.239600E-02 |
| Caucasian-vs-AfricanAmerican |
2.108800E-01 |
| Caucasian-vs-Asian |
6.662200E-01 |
| AfricanAmerican-vs-Asian |
9.956800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.5136999997889E-07 |
| Male-vs-Female |
1.641900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.58450047421854E-10 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
8.88178419700125E-16 |
| Normal-vs-Extreme_Obese |
4.059700E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.371800E-01 |
| Normal_Weight-vs-Obese |
8.799000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.967000E-01 |
| Extreme_Weight-vs-Obese |
1.650990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.887000E-01 |
| Obese-vs-Extreme_Obese |
8.118400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.889500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.53415083256914E-13 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.340760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.500000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.217900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.788800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.054300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.216630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
4.09620115604525E-11 |
| Normal-VS-KIRP CIMP |
1.608560E-01 |
| Normal-VS-Unclassified PRCC |
3.00269997755009E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.368400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.121200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.866190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.344000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.871200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.867800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.83690004820869E-09 |
| Normal-vs-N1 |
2.99879998610919E-09 |
| Normal-vs-N2 |
2.808400E-01 |
| N0-vs-N1 |
4.544800E-01 |
| N0-vs-N2 |
5.627800E-01 |
| N1-vs-N2 |
7.929000E-01 |
|
|
